Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

Mario Castro, James Zangrilli, Michael E. Wechsler et al. · The Lancet Respiratory Medicine · 2015 · 1.2K citations

Life Sciences, Immunology, Pharmacotherapy +11

Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study

Mario Castro, Sameer K. Mathur, Frederick E. Hargreave et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 718 citations

Life Sciences, Immunology, Pharmacotherapy +14

Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels

Leif Bjermer, Catherine Lemière, Jorge Máspero et al. · CHEST Journal · 2016 · 426 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma

Jonathan Corren, Steven F. Weinstein, Lindsay Janka et al. · CHEST Journal · 2016 · 383 citations

Medicine, Pharmacology, Pharmacotherapy +15

Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma

Kevin R. Murphy, Joshua Jacobs, Leif Bjermer et al. · The Journal of Allergy and Clinical Immunology In Practice · 2017 · 146 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14